TRETHERA CORP

Profile

Company Names

TRETHERA CORP
TRIANGLE THERAPEUTICS INC.

Addresses

13547 VENTURA BLVD., SUITE 363, SHERMAN OAKS, CA 91423-3825

13547 VENTURA BLVD., SUITE 363, LOS ANGELES, CA 91423

11601 WILSHIRE BLVD., FIFTH FLOOR, LOS ANGELES, CA 90025

3201 WILSHIRE BLVD., SUITE 102, SANTA MONICA, CA 90403

9350 WILSHIRE BLVD., SUITE 214, BEVERLY HILLS, CA 90212

10900 WILSHIRE BLVD., SUITE 850, LOS ANGELES, CA 90024

Phone Numbers

310-997-2788
424-223-6949
(310) 405-7212

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

CALIFORNIA

Total Amount Raised:

$35,054,115.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2025-04-29 
$250,000.00 
$5,000,000.00 
$4,750,000.00 
Equity 
7
2021-06-26 
$3,833,592.00 
INDEFINITE 
INDEFINITE 
Equity 
6
2020-02-25 
$3,253,368.00 
$3,253,368.00 
$0.00 
Equity 
5
2019-04-05 
$580,500.00 
$10,000,000.00 
$9,419,500.00 
Equity 
4
2019-03-08 
$8,056,505.00 
$8,056,505.00 
$0.00 
Equity 
3
2017-02-23 
$4,175,557.00 
$5,000,667.00 
$825,110.00 
Equity 
2
2016-02-10 
$10,049,743.00 
$20,000,000.00 
$9,950,257.00 
Equity 
1
2015-04-10 
$4,854,850.00 
$6,006,000.00 
$1,151,150.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHANNES 
 
CZERNIN 
DIRECTOR
SOFIE BIOSCIENCES, INC.   |  TRIANGLE THERAPEUTICS INC.   |  TRETHERA CORP
JEAN 
 
DEKERNION 
DIRECTOR
TRIANGLE THERAPEUTICS INC.
JEAN 
B. 
DEKERNION 
DIRECTOR, EXECUTIVE OFFICER
TRETHERA CORP
TIMOTHY 
 
DONAHUE, M.D. 
DIRECTOR
TRETHERA CORP
LAURENT 
 
DUBOIS 
DIRECTOR
MENTA GLOBAL, LP   |  MENTA GLOBAL OFFSHORE LTD   |  MENTA GLOBAL MASTER L.P.   |  TRETHERA CORP   |  ADB SAFEGATE LUXEMBOURG HOLDCO S.A R.L.
LOUIS 
L. 
GONDA 
DIRECTOR
TRIANGLE THERAPEUTICS INC.   |  TRETHERA CORP
JOHANNA 
 
HOLLDACK 
EXECUTIVE OFFICER, DIRECTOR
TRETHERA CORP
NATHAN 
 
MATA 
EXECUTIVE OFFICER
REVISION THERAPEUTICS, INC.   |  TRETHERA CORP
CARL 
 
MCKINZIE 
EXECUTIVE OFFICER, DIRECTOR
TRIANGLE THERAPEUTICS INC.   |  ATHOS THERAPEUTICS, INC.   |  TRETHERA CORP
CARL 
W. 
MCKINZIE 
EXECUTIVE OFFICER, DIRECTOR
TRETHERA CORP   |  SOFIE BIOSCIENCES, INC.
R. 
BOYD 
QUINNELL 
DIRECTOR
TRETHERA CORP
CAIUS 
 
RADU 
DIRECTOR
TRIANGLE THERAPEUTICS INC.   |  TRETHERA CORP
LYNNE 
 
ROLLINS 
EXECUTIVE OFFICER
HELIXIS INC   |  SONEXA THERAPEUTICS INC   |  NANOTHERA CORP   |  ABREXA PHARMACEUTICALS, INC.   |  SONEXA THERAPEUTICS, INC   |  BIONANO GENOMICS, INC   |  WIRELESS DIAGNOSTIC SYSTEMS, INC.   |  TRETHERA CORP   |  GENE SCIENCES, INC.   |  CHROMACODE, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
KENNETH 
A. 
SCHULTZ, M.D. 
EXECUTIVE OFFICER, DIRECTOR
TRETHERA CORP
JOHN 
 
STRETTON 
EXECUTIVE OFFICER
TRETHERA CORP
OWEN 
 
WITTE, M.D. 
DIRECTOR
TRETHERA CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-05-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-29 
2022-05-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-26 
2021-02-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-25 
2019-04-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-05 
2019-03-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-08 
2017-03-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-23 
2016-10-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-10 
2016-02-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-10 
2015-07-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-04-10 
2015-04-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-04-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NOBLES + RICHARDS INC.
146870
MICHAEL HUGHES
2124662